Filing metadata

Accession number
0001209191-17-033369
Form type
Form 4
Filer
Adamas Pharmaceuticals Inc
CIK
CIK 1328143
Filed
May 17, 2017
Reporting period
Jan 18, 2017
Description
Insider transaction

Explore SEC Filings Hub